|

VVD-133214 Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Vividion Therapeutics, Inc.2

Indications

  • Cancer2
  • Colorectal Adenocarcinoma1
  • Advanced Solid Tumors1
  • Colorectal Cancer1

Tucson, Arizona2 trials

A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum

University of Arizona Cancer Center - North Campus

Phase 2
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

University of Arizona Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.